共 50 条
- [1] Initial Combination Therapy With Macitentan And Tadalafil In Newly Diagnosed Patients With Pulmonary Arterial Hypertension: Results From The Optima Trial[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195Sitbon, O.Canuet, M.Picard, F.Prevot, G.Bergot, E.Cottin, V.Bauer, F.Degano, B.Gressin, V.Clerson, P.Simonneau, G.
- [2] INITIAL TREATMENT COMBINATION WITH MACITENTAN AND TADALAFIL IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: RESULTS FROM THE OPTIMA STUDY[J]. CHEST, 2019, 156 (04) : 870A - 871ASitbon, OlivierCanuet, MatthieuPicard, FrancoisGregoire, PrevotBergot, EmmanuelCottin, VincentBauer, FabriceDegano, BrunoGressin, VirginiePerchenet, LoicClerson, PierreSimonneau, Gerald
- [3] Initial Combination Therapy with Macitentan and Tadalafil in Pulmonary Arterial Hypertension[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201Marinescu, D.Christiansen, D.Thenganatt, J.Granton, J. T.
- [4] Initial combination therapy of macitentan and tadalafil in pulmonary arterial hypertension[J]. EUROPEAN RESPIRATORY JOURNAL, 2020, 56 (03)Sitbon, OlivierCottin, VincentCanuet, MatthieuClerson, PierreGressin, VirginiePerchenet, LoicBertoletti, LaurentBouvaist, HelenePicard, FrancoisPrevot, GregoireBergot, EmmanuelSimonneau, Gerald
- [5] Initial combination therapy with macitentan and tadalafil in patients with pulmonary arterial hypertension, with and without cardiac comorbidities[J]. EUROPEAN JOURNAL OF HEART FAILURE, 2024,McLaughlin, Vallerie V.Sitbon, OlivierChin, Kelly M.Galie, NazzarenoHoeper, Marius M.Kiely, David G.MacDonald, GwenMartin, NicolasMathai, Stephen C.Peacock, AndrewTawakol, AhmedTorbicki, AdamNoordegraaf, Anton VonkRosenkranz, Stephan
- [6] Macitentan tadalafil fixed dose combination (FDC) in patients with pulmonary arterial hypertension (PAH): A subgroup analysis from A DUE[J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 62Jansa, PavelChin, KellyGruenig, EkkehardHauser, JakobPannaux, MatthieuRofael, HanyFan, Fenling
- [7] INITIAL DATA FROM THE US PULMONARY HYPERTENSION REGISTRY: GENETICS AND DEMOGRAPHICS IN NEWLY DIAGNOSED PULMONARY ARTERIAL HYPERTENSION (PAH)[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 1926 - 1926Benza, RaymondFrost, AdaaniElliott, GregAustin, EricBadesch, DavidFarber, HarrisonChung, WendyPoms, AbbyFeldkircher, KathyYu, ChangBadlam, JessicaPauciulo, MichaelNichols, William
- [8] Efficacy and Safety of Initial Triple Oral Versus Initial Double Oral Combination Therapy in Patients with Newly Diagnosed Pulmonary Arterial Hypertension (PAH): Results of the Randomized Controlled TRITON Study[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201Chin, K. M.Sitbon, O.Doelberg, M.Gibbs, J. S. R.Hoeper, M. M.Martin, N.Mathai, S. C.McLaughlin, V. V.Perchenet, L.Simonneau, G.Galie, N.
- [9] Macitentan tadalafil Fixed Dose Combination (FDC) in treatment-naive and prior monotherapy patients with Pulmonary Arterial Hypertension (PAH): insights from A DUE[J]. EUROPEAN HEART JOURNAL, 2023, 44Gruenig, E.Jansa, P.Fan, F.Friberg, M.Lassen, C.Pannaux, M.Rofael, H.Chin, K.
- [10] Concomitant initiation of combination therapy with macitentan and tadalafil in pulmonary arterial hypertension (PAH) patients with comorbidities: real-world data from OPUS and OrPHeUS[J]. EUROPEAN HEART JOURNAL, 2022, 43 : 1916 - 1916Channick, R.Chin, K. M.Kim, N. H.Ong, R.Turricchia, S.Mitchell, L.McLaughlin, V. V.